Document is current
Any future updates will be listed below
-
Authors
Isufi, Daniel
Schwarz, Christopher Willy
Jensen, Mikkel Bak
Seidelin, Jakob
Skov, Lone
Loft, Nikolai
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 28 February 2025
Accepted: 18 May 2025
First Online: 25 June 2025
Declarations
:
: Mr. Isufi, Dr. Schwarz, and Dr. Jensen report no conflict of interest. Dr. Loft has been a paid speaker for Eli Lilly, Janssen Cilag, and Sandoz. Dr. Seidelin has received research grants from Takeda, Janssen, the Danish Research Council, and the Capital Region Denmark; and has served as the national coordinator of studies for AbbVie, Arena Pharmaceuticals, Ely Lilly, and Boehringer Ingelheim. Dr. Skov has been a paid speaker for AbbVie, Eli Lilly, Novartis, Pfizer, and LEO Pharma, and has been a consultant or has served on Advisory Boards with AbbVie, Janssen Cilag, Novartis, Eli Lilly, Boehringer Ingelheim, LEO Pharma, Takeda, Stada, UCB, Almirall, Bristol-Myers Squibb, and Sanofi and has received research and educational grants/funding from LEO Foundation, Kgl Hofbundtmager Aage Bang Foundation, Sanofi, Bristol-Myers Squibb, Janssen Cilag, and Almirall.
